 |
Neurocrine Biosciences
Last updated: August 28, 2024
Kevin C. Gorman, CEO
USA | Funding: $260M (+)
Website: https://www.neurocrine.com
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Website: https://www.neurocrine.com
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
